Anax Metals Limited (ASX: ANX) outlined its updated definitive feasibility study (DFS), highlighting strong economic metrics for its Whim Creek Copper-Zinc Project in Western Australia. I came across the Anax Metals story a couple of years ago, and it has finally come to a very interesting stage. This latest ASX release is probably a welcome update for existing shareholders.

Algorae Pharmaceuticals Ltd (ASX: 1AI) has taken a major step toward establishing a commercial presence in the Australian and New Zealand markets. The company has entered into an exclusive licensing agreement with global pharmaceutical manufacturer Sakar Healthcare Limited (NSE: SAKAR, BSE: 538377) (Figure 1) to launch five oncology medicines across the region.